Form D · Biotechnology

TISSUETECH, INC.

Miami, FL · CIK 0001560311

Offering snapshot reported Apr 12, 2019 · SEC filing

Reported sold
$55.3M
Offering amount: $82.3M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 9, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 12, 2019Initial$55,250,001No comparison3SEC filing
Jun 16, 2015Initial$15,000,000No comparison7SEC filing
Oct 10, 2013Initial$1,417,500No comparison13SEC filing
Aug 23, 2013Initial$10,000,000No comparison3SEC filing
Oct 15, 2012Initial$1,372,500No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-337196

Source: Form D, filed Apr 12, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Arnott Director
Devin Buckley Executive
Greg Collins Executive
Michael Cornelinus Executive
Michael Cornelius Executive
William Hawkins Director
Jane Hsiao Director
Carter Mcnabb Director
Carter Mc Nabb Director
Martin Nutter Director
Matt Rice Director
Amy H. Tseng Director, Executive
Scheffer C.G. Tseng Director, Executive
Billy K. Yeh Director
Brian Yeh Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
7300 Corporate Center Drive Suite 700
Miami, FL, 33126